Vident Investment Advisory, LLC / ABT
Vident Investment Advisory, LLC’s Abbott Laboratories Position
Does Vident Investment Advisory, LLC own Abbott Laboratories (ABT)? Not currently — the last reported position was 251.7K shares worth $27M in Q2 2023; the fund’s latest 13F (Q3 2023) no longer reports it.
Position Value
$27M
Q2 2023
Shares
251.7K
% of Portfolio
+0.95%
Quarters Held
17
position exited
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2023 | 251.7K | $27M | +0.95% |
| Q1 2023 | 227.0K | $23M | +0.75% |
| Q4 2022 | 116.4K | $13M | +0.48% |
| Q3 2022 | 27.4K | $2M | +0.07% |
| Q2 2022 | 7.4K | $800,000 | +0.02% |
| Q1 2022 | 17.9K | $2M | +0.06% |
| Q4 2021 | 26.5K | $4M | +0.10% |
| Q3 2021 | 19.9K | $2M | +0.07% |
| Q2 2021 | 15.9K | $2M | +0.06% |
| Q1 2021 | 14.6K | $2M | +0.06% |
| Q4 2020 | 11.7K | $1M | +0.05% |
| Q3 2020 | 10.3K | $1M | +0.06% |
| Q2 2020 | 9.6K | $874,000 | +0.05% |
| Q1 2020 | 3.9K | $308,000 | +0.02% |
| Q2 2019 | 7.3K | $616,000 | +0.05% |
| Q1 2019 | 6.8K | $544,000 | +0.03% |
| Q4 2018 | 2.8K | $202,000 | +0.01% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Vident Investment Advisory, LLC’s full portfolio or all institutional holders of ABT.